Source: Site record. TRIO (Translational Research in Oncology)

TRIO (Translational Research in Oncology) is an independent, not-for-profit, full-service oncology contract research organization (CRO) established in 1997 with a mission to advance cancer research through high-quality, globally coordinated clinical trials. The organization specializes exclusively in oncology, supporting Phase I to Phase III studies across the entire clinical development lifecycle, including study design, regulatory management, monitoring, data management, biostatistics, medical writing, pharmacovigilance, and trial execution. TRIO operates through global hubs in North America, Europe, and Latin America, with a network of more than 500 experienced investigational sites across over 20 countries. Its translational research model integrates leading academic experts with clinical investigators to accelerate the development of innovative cancer therapies. Having enrolled more than 22,000 patients and contributed to several practice-changing oncology trials, TRIO is…